变量 | [ALL] | 未检出 | 检出 | P value |
N = 73 | N = 4 | N = 69 | ||
分组 |
|
|
| 0.049 |
纳米炭组 | 40 (48.2%) | 4 (100%) | 36 (52.1%) |
|
吲哚菁绿组 | 43 (51.8%) | 0 (0.00%) | 33 (47.8%) |
|
年龄 | 46.1 ± 10.6 | 64.0 ± 6.38 | 48.3 ± 10.2 | 0.003 |
病理分型 |
|
|
| 0.184 |
鳞癌 | 58 (81.5%) | 2 (50.0%) | 56 (81.1%) |
|
腺癌 | 15 (18.5%) | 2 (50.0%) | 13 (18.9%) |
|
分期 |
|
|
| 0.321 |
I期 | 58 (79.45%) | 2 (50.0%) | 56 (81.1%) |
|
II期 | 7 (9.58%) | 1 (25.0%) | 6 (8.69%) |
|
III期 | 8 (10.95%) | 1 (25.0%) | 7 (10.14%) |
|
新辅助化疗 | 5 (6.02%) | 0 (0.00%) | 5 (6.33%) | 0.580 |
锥切 | 21 (25.3%) | 0 (0.00%) | 21 (26.6%) | 0.194 |
肿瘤大小cm |
|
|
| 0.321 |
<2 cm | 13 (22.0%) | 2 (50.0%) | 11 (15.9%) |
|
2~4 cm | 33 (55.9%) | 1 (25.0%) | 32 (46.3%) |
|
≥4 cm | 13 (22.0%) | 1 (25.0%) | 12 (17.3%) |
|
肿瘤浸润深度 |
|
|
| 0.411 |
<1/3 | 25 (41.0%) | 1 (25.0%) | 24 (42.1%) |
|
1/3~2/3 | 22 (36.1%) | 1 (25.0%) | 21 (36.8%) |
|
>2/3或全层 | 14 (23.0%) | 2 (50.0%) | 12 (21.1%) |
|
手术路径 |
|
|
| 0.194 |
经腹 | 52 (71.2%) | 4 (100%) | 48 (69.5%) |
|
腹腔镜 | 21 (28.7%) | 0 (0.00%) | 21 (30.4%) |
|
脉管癌栓 |
|
|
| 0.419 |
阴 | 36 (55.4%) | 3 (75.0%) | 33 (54.1%) |
|
阳 | 29 (44.6%) | 1 (25.0%) | 28 (45.9%) |
|